DOES POST-FRACTURE THERAPY WITH BONE CONSERVATION AGENTS PREVENT SECOND FRACTURE? PRELIMINARY RESULTS FROM A STUDY OF 10,608 MALES

被引：0
|
作者：
Shepherd, Angela J. [1 ]
Cass, Alvah R. [1 ]
Howrey, Brett [1 ]
Wilkinson, Gregg S. [1 ]
机构：
[1] Univ Texas Med Branch, Galveston, TX USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S189 / S190
页数：2
相关论文
共 6 条
  • [1] A micro-costing analysis of post-fracture care pathways: results from the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)
    Talevski, J.
    Sanders, K. M.
    Lal, A.
    Watts, J. J.
    Beauchamp, A.
    Duque, G.
    Borgstrom, F.
    Kanis, J. A.
    Svedbom, A.
    Brennan-Olsen, S. L.
    OSTEOPOROSIS INTERNATIONAL, 2022, 33 (09) : 1895 - 1907
  • [2] A micro-costing analysis of post-fracture care pathways: results from the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)
    J. Talevski
    K. M. Sanders
    A. Lal
    J. J. Watts
    A. Beauchamp
    G. Duque
    F. Borgström
    J. A. Kanis
    A. Svedbom
    S. L. Brennan-Olsen
    Osteoporosis International, 2022, 33 : 1895 - 1907
  • [3] Fracture rate in perimenopausal women is not dependent on previous change in bone mineral density. Preliminary results from prospective population-based study.
    Huopio, J
    Kroger, H
    Honkanen, R
    Saarikoski, S
    Alhava, E
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S295 - S295
  • [4] Bone Fracture Incidence After Androgen Deprivation Therapy-Investigational Agents: Results From Cancer Therapy Evaluation Program-Sponsored Early Phase Clinical Trials 2006-2013
    Myint, Zin W.
    Kunos, Charles A.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [5] Does Serial Bone Density Measurement Meaningfully Improve Incident Fracture Risk Prediction in Postmenopausal Women? Results from the Women's Health Initiative Observational Study and Clinical Trials
    Crandall, Carolyn
    Larson, Joseph
    Wright, Nicole
    Laddu, Deepika
    Stefanick, Marcia
    Kaunitz, Andrew
    Watts, Nelson
    Wactawski-Wende, Jean
    Womack, Catherine
    Johnson, Karen
    Carbone, Laura
    Jackson, Rebecca
    Ensrud, Kristine
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 213 - 214
  • [6] Acitivity of new agents (NAs) as third-line treatment in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) showing a primary resistance (PRes) to NAs-based second line therapy after docetaxel (DOC): Preliminary results from a multicenter Italian study.
    Caffo, Orazio
    De Giorgi, Ugo
    Facchini, Gaetano
    Fratino, Lucia
    Gasparro, Donatello
    Basso, Umberto
    Alesini, Daniele
    Tucci, Marcello
    Ortega, Cinzia
    Verderame, Francesco
    Procopio, Giuseppe
    Lo Re, Giovanni
    Campadelli, Enrico
    Omarini, Claudia
    Donini, Maddalena
    Morelli, Franco
    Zucali, Paolo A.
    Sartori, Donata
    Conteduca, Vincenza
    Galligioni, Enzo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
1